Likelihood of Trying Long-Acting Injectable Antiretroviral Therapy Among Women With HIV in Nine Sites Across the United States

被引:2
作者
Mccrimmon, Tara [1 ]
Collins, Lauren F. [2 ]
Pereyra, Margaret [1 ]
Platamone, Corbin [3 ]
Perez-Brumer, Amaya [4 ]
Shaffer, Victoria A. [5 ]
Kerrigan, Deanna [6 ]
Sheth, Anandi N. [2 ]
Cohen, Mardge H. [7 ]
Hanna, David B. [8 ]
Ramirez, Catalina [9 ]
Gange, Stephen J. [10 ]
Rana, Aadia [11 ]
Tamraz, Bani [12 ]
Goparaju, Lakshmi [13 ]
Wilson, Tracey E. [14 ]
Alcaide, Maria [15 ]
Philbin, Morgan M. [16 ]
机构
[1] Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, New York, NY 10027 USA
[2] Emory Univ, Sch Med, Dept Med, Atlanta, GA USA
[3] Univ Calif San Francisco, Dept Med, Benioff Homelessness & Housing Initiat, San Francisco, CA USA
[4] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada
[5] Univ Missouri, Dept Psychol Sci, Columbia, MO USA
[6] George Washington Univ, Milken Inst Sch Publ Hlth, Dept Prevent & Community Hlth, Washington, DC USA
[7] John H Stroger Jr Hosp Cook Cty, Dept Med, Chicago, IL USA
[8] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY USA
[9] Univ N Carolina, Sch Med, Div Infect Dis, Carrboro, NC USA
[10] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[11] Univ Alabama Birmingham, Heersink Sch Med, Dept Med, Birmingham, AL USA
[12] Univ Calif San Francisco, Sch Pharm, San Francisco, CA USA
[13] Georgetown Univ Med Ctr, Sch Med, Washington, DC USA
[14] SUNY Downstate Hlth Sci Univ, Sch Publ Hlth, Dept Community Hlth Sci, Brooklyn, NY USA
[15] Univ Miami, Miller Sch Med, Dept Med, Miami, FL USA
[16] Univ Calif San Francisco, Div Hlth Equ & Soc, San Francisco, CA USA
关键词
IMPLEMENTATION; CABOTEGRAVIR; RILPIVIRINE; BARRIERS;
D O I
10.1097/QAI.0000000000003422
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:e23 / e27
页数:5
相关论文
共 35 条
  • [1] Cohort Profile: The Women's Interagency HIV Study (WIHS)
    Adimora, Adaora A.
    Ramirez, Catalina
    Benning, Lorie
    Greenblatt, Ruth M.
    Kempf, Mirjam-Colette
    Tien, Phyllis C.
    Kassaye, Seble G.
    Anastos, Kathryn
    Cohen, Mardge
    Minkoff, Howard
    Wingood, Gina
    Ofotokun, Igho
    Fischl, Margaret A.
    Gange, Stephen
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2018, 47 (02) : 393 - +
  • [2] [Anonymous], 2023, HIV in the US | HIV Statistics Center | HIV | CDC
  • [3] [Anonymous], 2024, LATITUDE Phase III Interim Trial Data Indicates ViiV Healthcare's Long-Acting Injectable HIV Treatment Cabenuva (Cabotegravir + Rilpivirine) Has Superior Efficacy Compared to Daily Therapy in Individuals Living with HIV Who Have Adherence Challenges | GSK
  • [4] Understanding Cross-Sectional Racial, Ethnic, and Gender Disparities in Antiretroviral Use and Viral Suppression Among HIV Patients in the United States
    Beer, Linda
    Mattson, Christine L.
    Bradley, Heather
    Skarbinski, Jacek
    [J]. MEDICINE, 2016, 95 (13) : e3171
  • [5] Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy
    Benning, Lorie
    Mantsios, Andrea
    Kerrigan, Deanna
    Coleman, Jenell S.
    Golub, Elizabeth
    Blackstock, Oni
    Konkle-Parker, Deborah
    Philbin, Morgan
    Sheth, Anandi
    Adimora, Adaora A.
    Cohen, Mardge H.
    Seidman, Dominika
    Milam, Joel
    Kassaye, Seble G.
    Taylor, Tonya
    Murray, Miranda
    [J]. BMC WOMENS HEALTH, 2020, 20 (01)
  • [6] Women and HIV in the United States
    Breskin, Alexander
    Adimora, Adaora A.
    Westreich, Daniel
    [J]. PLOS ONE, 2017, 12 (02):
  • [7] CDC, HIV Surveillance Supplemental Report 20202020
  • [8] First Demonstration Project of Long-Acting Injectable Antiretroviral Therapy for Persons With and Without Detectable Human Immunodeficiency Virus (HIV) Viremia in an Urban HIV Clinic
    Christopoulos, Katerina A.
    Grochowski, Janet
    Mayorga-Munoz, Francis
    Hickey, Matthew D.
    Imbert, Elizabeth
    Szumowski, John D.
    Dilworth, Samantha
    Oskarsson, Jon
    Shiels, Mary
    Havlir, Diane
    Gandhi, Monica
    [J]. CLINICAL INFECTIOUS DISEASES, 2023, 76 (03) : E645 - E651
  • [9] Are Patients and Their Providers Talking About Long-Acting Injectable Antiretroviral Therapy? Penetration into Clinical Encounters at Three US Care Sites
    Christopoulos, Katerina A.
    Colasanti, Jonathan
    Johnson, Mallory O.
    Tsuzuki, Manami Diaz
    Erguera, Xavier A.
    Flores, Rey
    Kerman, Jared
    Dance, Kaylin
    Sauceda, John A.
    Neilands, Torsten B.
    Dilworth, Samantha E.
    Koester, Kimberly A.
    Gutierrez, Jose
    Schneider, John A.
    Montgomery, Elizabeth
    McNulty, Moira C.
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (07):
  • [10] Acceptability and preferences for long-acting antiretroviral formulations among people with HIV infection
    Dandachi, Dima
    Dang, Bich N.
    Lucari, Brandon
    Swindells, Susan
    Giordano, Thomas P.
    [J]. AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2021, 33 (06): : 801 - 809